<DOC>
	<DOCNO>NCT01105299</DOCNO>
	<brief_summary>The purpose study characterize compare bioequivalence CJ anastrozole [ CJ Cheiljedang corp. , Seoul , Korea ] Arimidex® [ AstraZeneca , Wilmington , DE , USA ] .</brief_summary>
	<brief_title>Bioequivalence Study Anastrozole 1 mg Tablet</brief_title>
	<detailed_description>This study conduct characterize compare pharmacokinetic safety profile bioequivalence newly develop new generation aromatase inhibitor ( CJ anastrozole ) exist anastrozole formulation ( Arimidex® ) healthy Korean volunteer . This study design single-dose , randomize , double-blind , 2-way crossover trial . Participants randomize receive 1 mg either CJ anastrozole Arimidex , follow 3-week washout period . And alternate formulation administer . After 10-hour overnight fast drug administer . For analysis pharmacokinetic property , include Cmax AUClast , blood sample obtain 0.33 , 0.67 , 1 , 1.5 , 2 , 3 , 4 , 6 , 8 , 12 , 24 , 48 , 72 , 96 , 120 , 168 , 216 hour drug administration .</detailed_description>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Healthy male volunteer age 19 55 year old Subjects neither congenital chronic disease . Subjects select pass clinical screening procedure include physical examination laboratory test . Availability subject entire study period willingness adhere protocol requirement , evidence sign Informed Consent Form . Any history clinical condition might affect drug absorption , distribution , metabolism excretion might risk factor , e.g . clinically significant disorder heart , liver , respiratory system , liver , kidney , gastrointestinal system CNS Had history myocardial infarction , stroke , hypertension , arrhythmia , coronary artery disease , disease neuropsychiatry , gastrointestinal system surgery ( exclude appendectomy , herniotomy ) Current clinically significant disorder history take physical examination Acute disease within 14 day precede first application study medication Had relevant allergic disease Had history hypersensitivity drug food Positive Hepatitis B antigen , Hepatitis C antibody , HIV antibody , High Quality Syphilis Reagin Test Excessive caffeine , alcohol intake smoker ( caffeine &gt; 5 units/day , alcohol &gt; 3 units/day ( 1 unit = pure alcohol 10ml ) , cigarettes &gt; 20 cigarette /day ) Subjects excessive alcohol intake drug affect drug metabolism enzyme intake within 30 day precede study History drug abuse positive urinary test drug abuse ( amphetamine , barbiturate , cocaine , opioids , benzodiazepine etc . ) Has donate whole blood within 60days apheresis within 14days precede first application study medication Received investigational drug within 60days precede first application study medication Taken herbal medicine within 30days , prescription medication within 14 day overthecounter drug ( except vitamin , mineral ) within 10days precede first application study medication ( might affect study safety subject judge investigator ) Subjects could eat ASAN MEDICAL CENTER standard meal unsuitable study judge investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>anastrozole</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>Antineoplastic Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Enzyme Inhibitors</keyword>
</DOC>